Articles with the keyword: 


Safer fetal test for genetic diseases on horizon
sea-maid submitted, created time 4 days 14 hours (www.newscientist.com)
Using just a drop of the mother's blood, scientists can now tell if the fetus has a disorder like cystic fibrosis – it could soon spell the end for invasive techniques 


Case Western Reserve finds mechanism underlying alt. splicing of premessenger RNA into messenger RNA
piggy submitted, created time 1 week 5 days (www.eurekalert.org)
An international research team led by Tim Nilsen, Ph.D., a professor of medicine and biochemistry and the director of the School of Medicine's Center for RNA Molecular Biology, has discovered an unexpected mechanism governing alternative splicing, the process by which single genes produce different proteins in different situations 


Personal genomes: The case of the missing heritability
sea-maid submitted, created time 1 month 4 weeks (www.nature.com)
When scientists opened up the human genome, they expected to find the genetic components of common traits and diseases. But they were nowhere to be seen. Brendan Maher shines a light on six places where the missing loot could be stashed away. 
Genomic medicine sector "needs government backing"
kavin submitted, created time 6 months 2 days (www.scidev.net)
Government support, strong leadership within institutions and the protection of "genomic sovereignty" are vital to the burgeoning genomic medicine sector in developing countries, say researchers.
Some developing countries are starting to use genomic science, aiming both for public health benefits and to produce knowledge to stimulate their economies. They often do this by setting up large-scale genotyping projects to assess susceptibility to disease 


Loss-of-function genetic diseases and the concept of pharmaceutical targets
Reviver submitted, created time 1 year 6 months (www.ojrd.com)
"The biomedical world relies heavily on the definition of pharmaceutical targets as an essential step in the drug design process. It is therefore tempting to apply this model to genetic diseases as well. However, whereas the model applies well to gain-of-function genetic diseases, it is less suited to most loss-of-function genetic diseases. Most common diseases, as well as gain-of-function genetic diseases, are characterized by the activation of specific pathways or the ectopic activity of proteins, which make well identified targets 
\ 1
\